Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: Role of tumor necrosis factor

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 4, 2000, Pages 412-421

  Fan, Jie ^a   Kapus, Andras ^a   Li, Yue H ^a   Rizoli, Sandro ^a   Marshall, John C ^a   Rotstein, Ori D ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; RODENTIA;

EID: 0034037521     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.4.3857     Document Type: Article

References (53)

1. Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. E. Petty, and T. M. Heyers. 1983. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 9:293-298.
2. Faist, E., A. E. Baue, H. Dittmer, and G. Heberer. 1983. Multiple organ failure in polytrauma patients. J. Trauma 23:775-787.
3. Moore, F. A., and E. E. Moore. 1995. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg. Clin. North Am. 75:257-277.
4. Zallen, G., E. E. Moore, J. L. Johnson, D. Y. Tamura, J. Aiboshi, and W. L. S. Biffl. 1999. Circulating postinjury neutrophils are primed for the release of proinflammatory cytokines. J. Trauma 46:42-48.
5. Botha, A. J., F. A. Moore, E. E. Moore, F. J. Kim, A. Banerjee, and V. M. Peterson. 1995. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery 118:358-364.
6. Hogg, J. C. 1987. Neutrophil kinetics and lung injury. Physiol. Rev. 67:1249-1295.
7. Fan, J., J. C. Marshall, M. Jimenez, P. N. Shek, J. Zagorski, and O. D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J. Immunol. 161:440-447.
8. Rizoli, S., A. Kapus, J. Fan, Y. Li, J. C. Marshall, and O. D. Rotstein. 1998. Immunomodulatory effects of hypertonic resuscitation tin the development of lung injury following hemorrhagic shock. J. Immunol. 161:6288-6296.
9. Naziri, W., J. D. Pietsch, S. H. Appel, W. G. Cheadle, T. M. Bergamini, and H. C. Polk, Jr. 1995. Hemorrhagic shock-induced alterations in circulating and bronchoalveolar macrophage nitric oxide production. J. Surg. Res. 59:146-152.
10. Bachofen, M., and E. R. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3:35-56.
11. Plow, E. F., D. Freaney, and T. S. Edgington. 1982. Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides. J. Immunol. 128: 1595-1599.
12. Ferrara, J. J., C. Kan, A. Luterman, and P. W. Curreri. 1989. Effects of fibrinogen degradation fragments D and E on cell-mediated immunity. J. Surf. Res. 47:134-137.
13. Senior, R. M., W. F. Skogen, G. L. Griffen, and G. D. Wilner. 1986. Effects of fibrinogen derivatives upon the inflammatory response. J. Clin. Invest. 77:1014-1019.
14. Sueishi, K., S. Nanno, and K. Tanaka. 1981. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Thromb. Haemost. 45:90-94.
15. Brown, L. F., A. M. Dvorak, and H. F. Dvorak. 1989. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumours and to many other types of disease. Am. Rev. Respir. Dis. 140:1104-11117.
16. Dvorak, H. F., D. M. Form, E. J. Manseau, and B. D. Smith. 1984. Pathogenesis of desmoplasia: I. Immunofluorcscence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J. Natl. Cancer Inst. 73:1195-1205.
17. Dvorak, H. F., V. S. Harvey, P. Estrella, L. F. Brown, J. McDonagh, and A. M. Dvorak. 1987. Fibrin containing gels induce angiogenesis: implications for tumor stroma generation and wound healing. Lab. Invest. 57:673-686.
18. Idell, S., K. Gonzalez, H. Bradford, C. K. MacArthur, A. M. Fein, R. J. Maunder, J. G. Garcia, D. E. Griffith, J. Weiland, T. R. Martin, J. McLarty, D. S. Fair, P. N. Walsh, and R. W. Colman. 1987. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome: contribution of tissue factor associated with factor VII. Am. Rev. Respir. Dis. 136:1466-1474.
19. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T. R. Maring, J. McLarty, and D. S. Fair. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84: 695-705.
20. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman, Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322: 890-897.
21. Sitrin, R. G., P. G. Brubaker, and J. C. Fantone. 1987. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities. Am. Rev. Respir. Dis. 135: 930-936.
22. Idell, S., K. K. James, C. Gillies, D. S. Fair, and R. S. Thrall. 1989. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J. Pathol. 135:387-399.
23. Seeger, W., J. Hubel, K. Klapettek, U. Pison, U. Obertacke, T. Joka, and L. Roka. 1991. Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to the development of acute respiratory distress. Thromb. Res. 61:53-64.
24. Nathens, A. B., J. C. Marshall, R. W. Watson, A. P. Dackiw, and O. D. Rotstein. 1996. Diethylmaleate attenuates endotoxin-induced lung injury. Surgery 120:360-366.
25. Coligan, J. E., A. M. Kruisbeck, D. H. Margulies, E. M. Shevach, and W. Strober. 1991. Isolation of murine macrophages. In Current Protocols in Immunology. John Wiley and Sons, Brooklyn. 14.1.3
26. Dackiw, A. P., A. B. Nathens, M. B. Ribeiro, P. Y. Cheung, J. C. Marshall, and O. D. Rotstein. 1995. Mast cell modulation of macrophage procoagulant activity and TNF production. J. Surg. Res. 59:1-5.
27. Nathens, A. B., O. D. Rotstein, A. P. Dackiw, and J. C. Marshall. 1995. Intestinal epithelial cells down-regulate macrophage tumor necrosis factor- alpha secretion: a mechanism for immune homeostasis in the gut-associated lymphoid tissue. Surgery 118:343-350.
28. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
29. Blackwell, T. S., T. R. Blackwell, E. P. Holden, B. W. Christman, and J. W. Christman. 1996. In vivo antioxidant treatment suppresses nuclear factor- kappa B activation and neutrophilic lung inflammation. J. Immunol. 157: 1630-1637.
30. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
31. Deryckere, F., and F. Gannon. 1994. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16:405.
32. Garner, M. M., and A. Revzin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: applications to components of Escherichia coli lactose regulatory system. Nucleic Acids Res. 9:3047-3060.
33. Fan, S.-T., N. Mackman, M.-Z. Cui, and T. S. Edgington. 1995. Integrin regulation of an inflammatory effector gene: direct induction of the tissue factor promoter by engagement of α1 or α4 integrin chains. J. Immunol. 154:3266-3274.
34. Jeong, J. Y., and D. M. Jue. 1997. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol. 158:4901-4907.
35. Allen, R. C. 1986. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 133:449-493.
36. Gross, T. J., R. H. Simon, and R. G. Sitrin. 1992. Tissue factor procoagulant expression by rat alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 6:397-403.
37. Bevilacqua, M. P., J. S. Pober, G. R. Majeau, W. Fiers, R. S. Cotran, and M. A. J. Gimbrone. 1986. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA 83:4533-4537.
38. Car, B. D., D. O. Slauson, M. M. Suyemoto, M. Dore, and N. R. Neilsen. 1991. Expression and kinetics of induced procoagulant activity in bovine pulmonary alveolar macrophages. Exp. Lung Res. 17:939-957.
39. Mackman, N., K. Brand, and T. S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J. Exp. Med. 174:1517-1526.
40. Schwager, I., and T. W. Jungi. 1994. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 83:152-160.
41. Gross, T. J., R. H. Simon, C. J. Kelly, and R. G. Sitrin. 1991. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am. J. Physiol. (Lung Cell Mol. Physiol.)4:L286-L295.
42. van den Berg. E. A., E. D. Sprengers, M. Jaye, W. Burgess, T. Maciag, and V. W. vanHinsbergh. 1988. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb. Haemost. 60:63-67.
43. Yamashita, M. 1997. Tumor necrosis factor alpha is involved in the induction of plasminogen activator inhibitor-1 by endotoxin. Thromb. Res. 87: 165-170.
44. Sawdey, M. S., and D. J. Loskutoff. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J. Clin. Invest. 88:1346-1353.
45. McLeish, K. R., C. Knall, R. A. Ward, P. Gerwins, P. Y. Coxon, J. B. Klein, and G. L. Johnson. 1998. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J. Leukoc. Biol. 64:537-545.
46. Jersmann, H. P., D. A. Rathjen, and A. Ferrante. 1998. Enhancement of lipopolysaccharide-induced neutrophil oxygen radical production by tumor necrosis factor alpha. Infect. Immun. 66:1744-1747.
47. Hybertson, B. M., E. K. Jepson, O. J. Cho, J. H. Clarke, Y. M. Lee, and J. E. Repine. 1997. TNF mediates lung leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. Am. J. Respir. Crit. Care Med. 155:1972-1976.
48. Ulich, T. R., S. Yin, D. G. Remick, D. Russell, S. P. Eisenberg, and T. Kohno. 1993. Intratracheal administration of endotoxin and cytokines: IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am. J. Pathol. 142:1335-1338.
49. Ulich, T. R., L. R. Watson, S. M. Yin, K. Z. Guo, P. Wang, H. Thang, and J. del Castillo. 1991. The intratracheal administration of endotoxin and cytokines: I. Characterisation of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138:1485-1496.
50. Moine, P., R. Shenkar, D. Kaneko, Y. Le Tulzo, and E. Abraham. 1997. Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs. Am. J. Physiol. 273:L185-L192.
51. Shenkar, R., M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord, and E. Abraham. 1996. Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo. Am. J. Physiol. 270:L729-L735.
52. Mendez, C., I. Garcia, and R. V. Maier. 1996. Oxidants augment endotoxin-induced activation of alveolar macrophages. Shock 6:157-163.
53. Szabo, C., and T. R. Billiar. 1999. Novel roles of nitric oxide in hemorrhagic shock. Shock 12:1-9.